In the News
Breakthrough Randomized Controlled Trial Demonstrating TWO2 Efficacy in Healing Diabetic Foot Ulcers unveiled at the American Diabetes Association 78th Scientific Sessions Conference
This breakthrough study unequivocally demonstrates at the highest scientific level the efficacy of Cyclical Pressure Topical Wound Oxygen Therapy in healing Diabetic Foot Ulcers” stated Dr. Robert Frykberg, the Chief Principle Investigator of the study.
Unprecedented Study Results Demonstrating Topical Wound Oxygen Effectiveness Presented at Major Wound Care Conferences
The study was a two-year retrospective review of 71 patients with a total of 115 wounds treated by a Veterans Affairs hospital in Chicago that prescribed cyclical pressurized TWO2 therapy for use at home.
AOTI Inc. Announces New York City Office Grand Opening
AOTI Inc. announced today that its fully owned USA-operating subsidiary, Advanced Oxygen Therapy Inc., has recently opened a New York City Office in Yonkers, New York to support the ever-increasing usage of its unique Topical Wound Oxygen (TWO2) homecare therapy. This new East Coast location has also been approved by the Accreditation Commission for Health Care (ACHC) under the company’s DMEPOS accreditation for Home/Durable Medical Equipment Services.
Topical Wound Oxygen (TWO2) Therapy Receives Strong Evidence Based Treatment Recommendations
OCEANSIDE, Calif., May 10, 2017 /PRNewswire/ -- AOTI Inc. announced today that its revolutionary...
AOTI exceeds 1,000,000 home treatments with its revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Apr 3 – AOTI Inc. announced today that over 1,000,000 home treatments...
AOTI Announces DMEPOS accreditation for Home & Durable Medical Equipment Services
Oceanside, California USA, Feb 17 – AOTI Inc. announced today that it’s fully owned USA operating...
AOTI Announces Expansive Clinical Education Program for Desert Foot and Podiatric Residency Summits
Oceanside, California USA, Feb 14 – AOTI Inc. announced today that it will again be providing an...
24th Patent Granted for AOTI’s revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Aug 16 – AOTI Inc. announced today the U.S. Patent and Trademark Office...
AOTI treats 10,000th patient with its revolutionary Topical Wound Oxygen Therapy
Oceanside, California USA, Apr 16 – AOTI Inc. announced today the 10,000th patient has been...
AOTI Announces Expansive Clinical Education Program for Desert Foot and Podiatric Residency Summits
Oceanside, California USA, Jan 11 – AOTI Inc. announced today that it will be providing an...